Article Text

Download PDFPDF
Correspondence
Patent foramen ovale closure and brain ischaemic lesions
  1. Enrico Ammirati1,
  2. Giancarlo Comi2,
  3. Paolo G Camici1
  1. 1Cardiovascular Department, Vita-Salute University and San Raffaele Scientific Institute, Milan, Italy
  2. 2Department of Neurology, Vita-Salute University and San Raffaele Scientific Institute, Milan, Italy
  1. Correspondence to Professor Paolo G Camici, Cardiovascular Department, Vita-Salute University and San Raffaele Scientific Institute, Milan, Italy; camici.paolo{at}hsr.it

Statistics from Altmetric.com

Request Permissions

If you wish to reuse any or all of this article please use the link below which will take you to the Copyright Clearance Center’s RightsLink service. You will be able to get a quick price and instant permission to reuse the content in many different ways.

Keywords

To the Editor The recently published meta-analysis by Wolfrum et al assessed the ability of percutaneous closure of patent foramen ovale (PFO) to reduce the incidence of recurrent stroke based on three randomised controlled clinical trials (RCT). This analysis did not demonstrate a superiority of the closure of PFO …

View Full Text

Footnotes

  • Contributors EA, GC and PGC wrote the manuscript.

  • Competing interests None.

  • Provenance and peer review Not commissioned; internally peer reviewed.

Linked Articles

  • PostScript
    Pascal Meier Mathias Wolfrum Georg M Froehlich Leanne K Casaubon Alexandra J Lansky